Letters by company
Everi Holdings Inc.
4 letters discussing EVRI. Everything written about it on this site is on its ticker page.
- Patient Capital Management 2Q24 Portfolio Activity and Attribution Patient Opportunity Equity increased exposure to underfollowed health-care and smaller-company opportunities while finding several Magnificent 7 holdings closer to fair value. It entered Everi Holdings and exited Capital One and Uber. The portfolio argues that Illumina, Biogen and Royalty Pharma offer mispriced health-care upside, while Everi’s IGT transaction should create a stronger casino-technology platform. 2Q24 AMZN $2.7TBIIB $33BCOIN $47B
- Palm Harbour Capital Letter 2024 Q1 Palm Harbour Capital bought Piraeus Port Authority, citing its cash generation, capacity expansion and recovery potential as trade routes normalize. The fund argues that IGT’s Everi merger creates additional risks but retains substantial value potential, while maintaining conviction in several discounted cash-rich holdings. Q1 2024 GHTI 0NV0 9824 $910M
- Patient Capital Management 3Q24 Portfolio Activity and Attribution Patient Opportunity Equity added QXO and Dave & Buster’s, funded in part by exits from JPMorgan and Everi following its acquisition. The portfolio argues that QXO’s acquisition-led building-products strategy, Kosmos’s approaching cash-flow inflection, and Seadrill’s tightening deepwater-rig market offer idiosyncratic upside beyond macro conditions. 3Q24 BABA $270BET $70BEXPE $31B
- Palm Harbour Capital Q3 2024 Letter Palm Harbour Capital sold Everi, PAX Technology and Unieuro, while adding M. Dias Branco, a Brazilian packaged-food leader working through post-inflation pricing and operational changes. The portfolio thesis centers on corporate actions at OCI, Ocean Wilson and IGT, alongside undervalued industrial, consumer and infrastructure holdings with identifiable catalysts. Q3 2024 DNIYY $4BIBST $429MOCINF $981M
